XO1 - Ownership and Business Overview

Life ScienceCompany

XO1 Ownership

Who owns XO1?

XO1 is owned by Janssen Pharmaceuticals. It was acquired on March 19, 2015.

XO1 Business Overview

Where is XO1 headquartered?

XO1 is headquartered in Babraham, United Kingdom.

What sector is XO1 in?

XO1 is a life science company.

When was XO1 founded?

XO1 was founded in 2013.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

XO1 Ltd.

Moneta Building, Babraham Research Campus,
Babraham, CB22 3AT
United Kingdom,
www.xo1.co.uk

XO1 Ltd. is an asset-centric virtual biopharmaceutical company. It is a developer of anti-thrombin antibody ichorcumab.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.